Bright Brothers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 14, 2025, 10:35 pm

Quick Insight

Bright Brothers Ltd, operating in the plastics industry, currently trades at a price of 377 with a market capitalization of 214 Cr. The company's P/E ratio stands at 23.3, reflecting investor confidence in its future earnings potential. With a ROE of 11.5% and ROCE of 16.2%, Bright Brothers demonstrates efficient use of capital. However, the OPM at 8.59% indicates room for improvement in operational efficiency. The company's healthy reserves of 71 Cr provide a cushion for future growth, although its borrowing of ₹54Cr warrants monitoring. Overall, Bright Brothers presents a solid investment opportunity, but efforts to enhance operational margins and reduce debt levels could further bolster its financial position.

Competitors of Bright Brothers Ltd

All Competitor Stocks of Bright Brothers Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:38 am

Below is a detailed analysis of the quarterly data for Bright Brothers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 85.49 Cr.. The value appears strong and on an upward trend. It has increased from 79.13 Cr. (Dec 2024) to 85.49 Cr., marking an increase of 6.36 Cr..
• For Expenses, as of Mar 2025, the value is 78.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 72.84 Cr. (Dec 2024) to 78.15 Cr., marking an increase of 5.31 Cr..
• For Operating Profit, as of Mar 2025, the value is 7.34 Cr.. The value appears strong and on an upward trend. It has increased from 6.29 Cr. (Dec 2024) to 7.34 Cr., marking an increase of 1.05 Cr..
• For OPM %, as of Mar 2025, the value is 8.59%. The value appears strong and on an upward trend. It has increased from 7.95% (Dec 2024) to 8.59%, marking an increase of 0.64%.
• For Other Income, as of Mar 2025, the value is 0.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.53 Cr. (Dec 2024) to 0.55 Cr., marking an increase of 0.02 Cr..
• For Interest, as of Mar 2025, the value is 2.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.03 Cr. (Dec 2024) to 2.70 Cr., marking an increase of 0.67 Cr..
• For Depreciation, as of Mar 2025, the value is 2.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.67 Cr. (Dec 2024) to 2.88 Cr., marking an increase of 0.21 Cr..
• For Profit before tax, as of Mar 2025, the value is 2.31 Cr.. The value appears strong and on an upward trend. It has increased from 2.12 Cr. (Dec 2024) to 2.31 Cr., marking an increase of 0.19 Cr..
• For Tax %, as of Mar 2025, the value is 20.35%. The value appears to be improving (decreasing) as expected. It has decreased from 55.66% (Dec 2024) to 20.35%, marking a decrease of 35.31%.
• For Net Profit, as of Mar 2025, the value is 1.84 Cr.. The value appears strong and on an upward trend. It has increased from 0.95 Cr. (Dec 2024) to 1.84 Cr., marking an increase of 0.89 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.24. The value appears strong and on an upward trend. It has increased from 1.67 (Dec 2024) to 3.24, marking an increase of 1.57.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:07 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 3:33 pm

Below is a detailed analysis of the balance sheet data for Bright Brothers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Reserves, as of Mar 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2024) to 71.00 Cr., marking an increase of 9.00 Cr..
• For Borrowings, as of Mar 2025, the value is 54.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 43.00 Cr. (Mar 2024) to 54.00 Cr., marking an increase of 11.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 100.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 89.00 Cr. (Mar 2024) to 100.00 Cr., marking an increase of 11.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 231.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 199.00 Cr. (Mar 2024) to 231.00 Cr., marking an increase of 32.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears strong and on an upward trend. It has increased from 116.00 Cr. (Mar 2024) to 145.00 Cr., marking an increase of 29.00 Cr..
• For Total Assets, as of Mar 2025, the value is 231.00 Cr.. The value appears strong and on an upward trend. It has increased from 199.00 Cr. (Mar 2024) to 231.00 Cr., marking an increase of 32.00 Cr..

Notably, the Reserves (71.00 Cr.) exceed the Borrowings (54.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bright Brothers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 14.95. This value is within the healthy range. It has increased from -8.39 (Mar 24) to 14.95, marking an increase of 23.34.
• For Diluted EPS (Rs.), as of Mar 25, the value is 14.95. This value is within the healthy range. It has increased from -8.39 (Mar 24) to 14.95, marking an increase of 23.34.
• For Cash EPS (Rs.), as of Mar 25, the value is 33.56. This value is within the healthy range. It has increased from 7.36 (Mar 24) to 33.56, marking an increase of 26.20.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.42. It has increased from 119.09 (Mar 24) to 134.42, marking an increase of 15.33.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.42. It has increased from 119.09 (Mar 24) to 134.42, marking an increase of 15.33.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 591.29. It has increased from 430.74 (Mar 24) to 591.29, marking an increase of 160.55.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 53.44. This value is within the healthy range. It has increased from 19.06 (Mar 24) to 53.44, marking an increase of 34.38.
• For PBIT / Share (Rs.), as of Mar 25, the value is 34.83. This value is within the healthy range. It has increased from 3.31 (Mar 24) to 34.83, marking an increase of 31.52.
• For PBT / Share (Rs.), as of Mar 25, the value is 19.20. This value is within the healthy range. It has increased from -8.27 (Mar 24) to 19.20, marking an increase of 27.47.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 14.95. This value is within the healthy range. It has increased from -8.39 (Mar 24) to 14.95, marking an increase of 23.34.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 14.95. This value is within the healthy range. It has increased from -8.39 (Mar 24) to 14.95, marking an increase of 23.34.
• For PBDIT Margin (%), as of Mar 25, the value is 9.03. This value is below the healthy minimum of 10. It has increased from 4.42 (Mar 24) to 9.03, marking an increase of 4.61.
• For PBIT Margin (%), as of Mar 25, the value is 5.89. This value is below the healthy minimum of 10. It has increased from 0.76 (Mar 24) to 5.89, marking an increase of 5.13.
• For PBT Margin (%), as of Mar 25, the value is 3.24. This value is below the healthy minimum of 10. It has increased from -1.91 (Mar 24) to 3.24, marking an increase of 5.15.
• For Net Profit Margin (%), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 5. It has increased from -1.94 (Mar 24) to 2.52, marking an increase of 4.46.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 8. It has increased from -1.94 (Mar 24) to 2.52, marking an increase of 4.46.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.12. This value is below the healthy minimum of 15. It has increased from -7.04 (Mar 24) to 11.12, marking an increase of 18.16.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.92. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 17.92, marking an increase of 16.11.
• For Return On Assets (%), as of Mar 25, the value is 3.67. This value is below the healthy minimum of 5. It has increased from -2.39 (Mar 24) to 3.67, marking an increase of 6.06.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has decreased from 0.23 (Mar 24) to 0.19, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.46, marking an increase of 0.14.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.56. It has increased from 1.33 (Mar 24) to 1.56, marking an increase of 0.23.
• For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has increased from 1.10 (Mar 24) to 1.13, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.89.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.99. This value exceeds the healthy maximum of 8. It has increased from 8.59 (Mar 24) to 8.99, marking an increase of 0.40.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -11.91 (Mar 24) to 0.00, marking an increase of 11.91.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.58 (Mar 24) to 0.00, marking a decrease of 13.58.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 111.91 (Mar 24) to 0.00, marking a decrease of 111.91.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.42 (Mar 24) to 0.00, marking a decrease of 86.42.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.42. This value is within the healthy range. It has increased from 1.65 (Mar 24) to 3.42, marking an increase of 1.77.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.96. This value is below the healthy minimum of 3. It has increased from 0.27 (Mar 24) to 1.96, marking an increase of 1.69.
• For Enterprise Value (Cr.), as of Mar 25, the value is 188.01. It has increased from 103.22 (Mar 24) to 188.01, marking an increase of 84.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.42 (Mar 24) to 0.55, marking an increase of 0.13.
• For EV / EBITDA (X), as of Mar 25, the value is 6.19. This value is within the healthy range. It has decreased from 9.53 (Mar 24) to 6.19, marking a decrease of 3.34.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.48, marking an increase of 0.11.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 111.91 (Mar 24) to 0.00, marking a decrease of 111.91.
• For Price / BV (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has increased from 1.37 (Mar 24) to 2.14, marking an increase of 0.77.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.48, marking an increase of 0.11.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to 0.05, marking an increase of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness